Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Shinji Miyazaki"'
Autor:
Machi Horiai, Ayano Otsuka, Shizu Hidema, Yuichi Hiraoka, Ryotaro Hayashi, Shinji Miyazaki, Tamio Furuse, Hiroaki Mizukami, Ryoichi Teruyama, Masaru Tamura, Haruhiko Bito, Yuko Maejima, Kenju Shimomura, Katsuhiko Nishimori
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Abstract Autism spectrum disorder (ASD) is a continuum of neurodevelopmental disorders and needs new therapeutic approaches. Recently, oxytocin (OXT) showed potential as the first anti-ASD drug. Many reports have described the efficacy of intranasal
Externí odkaz:
https://doaj.org/article/877a9c53f90b4d71bd32daef8a710a3a
Autor:
Hiroaki Oizumi, Shinji Miyazaki, Masahiro Tabuchi, Toshihiro Endo, Yuji Omiya, Kazushige Mizoguchi
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
The cognitive and psychological domains of frailty in the elderly have drawn increasing attention given the aging of society. However, therapeutics to treat minor deficits in cognition and mental state in the elderly remain an unmet need. Kamikihito
Externí odkaz:
https://doaj.org/article/8798f0d9347444458e8f7b430362c598
Publikováno v:
BPB Reports. 5:59-65
Autor:
Yosuke Matsubara, Yuko Miyama, Ryota Imai, Hiroaki Oizumi, Shinji Miyazaki, Eisuke Haneda, Keita Mizuno, Yuji Omiya, Yoshiki Ikeda, Kazushige Mizoguchi
Publikováno v:
Bioscience, Biotechnology, and Biochemistry.
As both physiological and psychological factors influence age-associated declines in older people, the development of drug therapy with multifaceted effects is required. To investigate the utility of ninjin'yoeito (NYT) against geriatric syndromes, w
Publikováno v:
Bioscience, biotechnology, and biochemistry. 85(11)
Dementia is exacerbated by loss of appetite and amotivation, and recent studies have indicated that ninjin'yoeito improves anorexia and amotivation. Previous studies suggest that ninjin'yoeito inhibits dopamine-metabolizing enzymes and enhances dopam
Autor:
Kengo Horie, Katsuhiko Nishimori, Satoru Takeda, Atsuo Itakura, Takashi Hirayama, Eri Kitamura, Shizu Hidema, Masato Koike, Tomokazu Fukuda, Shinji Miyazaki, Yuichi Hiraoka
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 46:66-78
Aim Previous reports showed associations between oxytocin induced labor and mental disorders in offspring. However, those reports are restricted in epidemiological analyses and its mechanism remains unclear. In this study, we hypothesized that induce
Autor:
Yuichi Hiraoka, Shinji Miyazaki, Haruhiko Bito, Yuko Maejima, Machi Horiai, Kenju Shimomura, Ryoichi Teruyama, Shizu Hidema, Hiroaki Mizukami, Ayano Otsuka, Katsuhiko Nishimori, Ryotaro Hayashi, Tamio Furuse, Masaru Tamura
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Autism spectrum disorder (ASD) is a continuum of neurodevelopmental disorders and needs new therapeutic approaches. Recently, oxytocin (OXT) showed potential as the first anti-ASD drug. Many reports have described the efficacy of intranasal OXT thera
Autor:
Yuji Omiya, Masahiro Tabuchi, Hiroaki Oizumi, Toshihiro Endo, Kazushige Mizoguchi, Shinji Miyazaki
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology
Frontiers in Pharmacology
The cognitive and psychological domains of frailty in the elderly have drawn increasing attention given the aging of society. However, therapeutics to treat minor deficits in cognition and mental state in the elderly remain an unmet need. Kamikihito
Autor:
Ji Hu, Ryo Takayama, Hisashi Sasagawa, Tatsuya Aono, Tomohiro Hidano, Shinji Miyazaki, Ryo Nadano, Junji Ichikawa, Masaki Fujiwara, Kohei Fuchibe
Publikováno v:
Synthesis. 50:514-528
The syntheses of fluorinated cyclopentanone derivatives, which have pharmaceutical and agrochemical importance are reported. The catalytic reaction of copper(I) and nickel(II) difluorocarbenes with silyl dienol ethers afforded 4,4-difluoro- and 5,5-d
Autor:
Yuji Omiya, Shinji Miyazaki, Yuko Miyama, Yoshiki Ikeda, Yosuke Matsubara, Eisuke Haneda, Ryota Imai
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 94:3-O